Display options
Cite
Abu-Madi MA, Al-Molawi N, Behnke JM. Seroprevalence and epidemiological correlates of Toxoplasma gondii infections among patients referred for hospital-based serological testing in Doha, Qatar. Parasit Vectors. 2008;1(1):39doi: 10.1186/1756-3305-1-39.
Abu-Madi, M. A., Al-Molawi, N., & Behnke, J. M. (2008). Seroprevalence and epidemiological correlates of Toxoplasma gondii infections among patients referred for hospital-based serological testing in Doha, Qatar. Parasites & vectors, 1(1), 39. https://doi.org/10.1186/1756-3305-1-39
Abu-Madi, Marawan A, et al. "Seroprevalence and epidemiological correlates of Toxoplasma gondii infections among patients referred for hospital-based serological testing in Doha, Qatar." Parasites & vectors vol. 1,1 (2008): 39. doi: https://doi.org/10.1186/1756-3305-1-39
Abu-Madi MA, Al-Molawi N, Behnke JM. Seroprevalence and epidemiological correlates of Toxoplasma gondii infections among patients referred for hospital-based serological testing in Doha, Qatar. Parasit Vectors. 2008 Oct 20;1(1):39. doi: 10.1186/1756-3305-1-39. PMID: 18937857; PMCID: PMC2586624.
Copy Download .nbib Format: NLM
Share it on

Parasit Vectors. 2008 Oct 20;1(1):39. doi: 10.1186/1756-3305-1-39.

Seroprevalence and epidemiological correlates of Toxoplasma gondii infections among patients referred for hospital-based serological testing in Doha, Qatar.

Parasites & vectors

Marawan A Abu-Madi, Naema Al-Molawi, Jerzy M Behnke

Affiliations

  1. School of Biology, University of Nottinghan, University Park, Nottingham, NG7 2RD, UK. [email protected].

PMID: 18937857 PMCID: PMC2586624 DOI: 10.1186/1756-3305-1-39

Abstract

BACKGROUND: The city of Doha in Qatar has a high density of feral cats and there is a high risk of toxoplasmosis for the resident human population. No data currently exist for the prevalence of infection with Toxoplasma gondii in the city.

METHODS: We analysed the serological response to Toxoplasma gondii of 1625 subjects referred for routine hospital based serological tests in Doha, Qatar. Prevalence of current/recent infection was assessed through an enzyme-linked immunosorbent assay (ELISA) for the presence of specific anti-T. gondii IgM antibodies, and previous history of infection through IgG.

RESULTS: Overall prevalence of IgG responses was 29.8% and this did not differ between the sexes nor between the three years of the study although there was a marked age effect. Among children less than 1 year old prevalence was 22.9%, but then dropped to <4% in the 1 year old group, indicating that these antibodies were most likely acquired in utero from immune mothers. Prevalence then increased steadily to peak at 41.2% among the oldest age class (>45 years). The prevalence of IgG antibody also varied significantly with region of origin, with higher rates for subjects from Africa, followed by those from the Eastern Mediterranean or Asia and lowest rates for subjects from the Arabian Peninsula. No IgM antibodies were detected in any subjects younger than 19 years, but prevalence increased to plateau at 7 - 9% in subjects aged over 20 years, and also varied with region of origin. In this case prevalence was highest among subjects from the Arabian Peninsula and least among those from Asia. Prevalence of IgM was higher among male subjects but did not vary between the three years of the study.

CONCLUSION: Although these data are based on a selected subset of the population, they nevertheless provide the first evidence that toxoplasmosis is endemic in Qatar in the human population, and that both age and region of origin play a role in the epidemiology of the infection. Concerns relating to the role of high density of feral cats in sustaining the infection were highlighted.

References

  1. Am J Trop Med Hyg. 1973 May;22(3):313-22 - PubMed
  2. East Mediterr Health J. 2008 Jan-Feb;14(1):163-71 - PubMed
  3. J Clin Microbiol. 2002 Nov;40(11):4037-44 - PubMed
  4. J Helminthol. 2008 Mar;82(1):59-68 - PubMed
  5. J Trop Med Hyg. 1985 Oct;88(5):301-6 - PubMed
  6. J Trop Med Hyg. 1976 Mar;79(3):67-70 - PubMed
  7. Clin Infect Dis. 1992 Aug;15(2):211-22 - PubMed
  8. Vet Parasitol. 2005 Sep 30;132(3-4):241-7 - PubMed
  9. Lancet. 2004 Jun 12;363(9425):1965-76 - PubMed
  10. Trends Parasitol. 2006 Mar;22(3):137-42 - PubMed
  11. Vet Parasitol. 2006 Jun 15;138(3-4):211-6 - PubMed
  12. Vet Parasitol. 1997 Dec 15;73(1-2):13-5 - PubMed
  13. Clin Microbiol Infect. 2005 Sep;11(9):719-23 - PubMed
  14. Reprod Toxicol. 2006 May;21(4):458-72 - PubMed
  15. Parasitol Today. 1994 Nov;10(11):419-23 - PubMed
  16. Epidemiol Infect. 1999 Apr;122(2):305-15 - PubMed
  17. Vet Res. 1998 May-Aug;29(3-4):289-310 - PubMed
  18. Int J Parasitol. 2000 Nov;30(12-13):1217-58 - PubMed
  19. J Egypt Soc Parasitol. 1989 Jun;19(1):225-9 - PubMed
  20. Ann Agric Environ Med. 2006;13(1):169-75 - PubMed
  21. Scand J Infect Dis Suppl. 1992;84:32-7 - PubMed
  22. J Helminthol. 2007 Sep;81(3):281-6 - PubMed
  23. Public Health. 2008 Apr;122(4):335-53 - PubMed
  24. Lancet. 1991 Jun 8;337(8754):1413-4 - PubMed
  25. FEMS Microbiol Rev. 2003 Dec;27(5):651-61 - PubMed
  26. J Parasitol. 1972 Oct;58(5):928-37 - PubMed
  27. Science. 1970 Feb 6;167(3919):893-6 - PubMed
  28. Hum Reprod. 1995 Dec;10(12):3297-300 - PubMed
  29. Semin Fetal Neonatal Med. 2007 Jun;12(3):214-23 - PubMed
  30. Practitioner. 1990 Jan 15;234(1481):42-4 - PubMed
  31. Trans R Soc Trop Med Hyg. 1980;74(2):209-12 - PubMed
  32. Trop Geogr Med. 1986 Sep;38(3):244-5 - PubMed
  33. Clin Microbiol Infect. 2002 Oct;8(10):634-40 - PubMed
  34. Arch Intern Med. 2002 Sep 23;162(17):1945-52 - PubMed
  35. Am J Med. 2005 Mar;118(3):212-6 - PubMed
  36. Vet Parasitol. 2004 Oct 5;124(3-4):167-77 - PubMed
  37. Saudi Med J. 2001 Jan;22(1):13-8 - PubMed
  38. Vet Parasitol. 1996 Aug;64(1-2):65-70 - PubMed
  39. Clin Infect Dis. 1996 Nov;23(5):1182-3 - PubMed

Publication Types